نتایج جستجو برای: myeloablative conditioning

تعداد نتایج: 48131  

Journal: :Haematologica 2009
J Luis Espinoza Akiyoshi Takami Makoto Onizuka Hiroshi Sao Hideki Akiyama Koichi Miyamura Shinichiro Okamoto Masami Inoue Yoshinobu Kanda Shigeki Ohtake Takahiro Fukuda Yasuo Morishima Yoshihisa Kodera Shinji Nakao

BACKGROUND NKG2D, an activating and co-stimulatory receptor expressed on natural killer cells and T cells, plays pivotal roles in immunity to microbial infections as well as in cancer immunosurveillance. This study examined the impact of donor and recipient polymorphisms in the NKG2D gene on the clinical outcomes of patients undergoing allogeneic T-cell-replete myeloablative bone marrow transpl...

Journal: :Blood 2013
Stéphanie C de Barros Rita Vicente Karim Chebli Chantal Jacquet Valérie S Zimmermann Naomi Taylor

Donor hematopoietic stem cells (HSCs) can correct T-cell deficiencies in patients with severe combined immunodeficiency by replacing resident thymus cells. However, as those progenitors that naturally migrate to the thymus are not capable of supporting long-term thymopoiesis, a successful transplant is thought to require the ongoing migration of donor progenitors. We previously showed that the ...

Journal: :Blood 2010
Joan Bladé Laura Rosiñol Maria Teresa Cibeira Montserrat Rovira Enric Carreras

Autologous stem cell transplantation (ASCT) is considered the gold standard in the frontline therapy of younger patients with multiple myeloma because it results in higher complete remission (CR) rates and longer event-free survival than conventional chemotherapy. The greatest benefit from ASCT is obtained in patients achieving CR after transplantation, the likelihood of CR being associated wit...

Journal: :Blood 2002
Steven M Devine Ron Hoffman Amit Verma Rajul Shah Basil A Bradlow Wendy Stock Vera Maynard Ellen Jessop David Peace Marianne Huml Deana Thomason Yi-Hsiang Chen Koen van Besien

Standard myeloablative conditioning prior to allogeneic hematopoietic stem cell (HSC) transplantation has been associated with significant toxicity in patients older than 45 years of age with myelofibrosis with myeloid metaplasia (MMM). We sought to evaluate the efficacy of a reduced-intensity conditioning regimen for allogeneic HSC transplantation in this setting. A regimen consisting of fluda...

2015
Flávia Machado Alves Basilio Fabiane Mulinari Brenner Betina Werner Graziela Junges Crescente Rastelli

BACKGROUND Permanent alopecia after bone marrow transplantation is rare, but more and more cases have been described, typically involving high doses of chemotherapeutic agents used in the conditioning regimen for the transplant. Busulfan, classically described in cases of irreversible alopecia, remains associated in recent cases. The pathogenesis involved in hair loss is not clear and there are...

نمودار تعداد نتایج جستجو در هر سال

با کلیک روی نمودار نتایج را به سال انتشار فیلتر کنید